Cabazitaxel 99% CAS 183133-96-2 oo loogu talagalay Kansarka Prostate Kastration-U adkaysta

Sharaxaad Gaaban:

Cabazitaxel waa API-ka-hortagga-tumor-ka taxan.Tijaabooyin caafimaad ayaa muujiyay in ay sidoo kale yarayn karto burooyinka, hoos u dhigi karto korriinka ama faafidda burooyinka, nafisinta calaamadaha kansarka qanjirka 'prostate' iyo hagaajinta tayada nolosha bukaanka.Cabazitaxel oo ay weheliso prednisone oo loogu talagalay daaweynta kansarka qanjirka 'prostate metastatic' ee hoormoonka-ka-hortagga ee horay loogu daaweeyay nidaam ka kooban docetaxel.Hand Bio waxay bixisaa cabazitaxel 99% CAS 183133-96-2 kansarka qanjirka 'prostate' u adkaysta.Faahfaahin dheeraad ah, fadlan waxaad xor u tahay inaad kala tashato khadka.


Faahfaahinta Alaabta

Tags Product

Macluumaadka Alaabta

Magaca:Cabazitaxel

Lambarka CAS:183133-96-2

Nafaqada kiimikada:C45H57NO14

Tilmaamaha:99%

Midabka:cad ama budo cad

Xigasho:Semi-ku-sameeyay 10-DAB

Nooca:API-yada

Shaqada

Tijaabooyin caafimaad ayaa muujiyay in cabazitaxel ay yarayn karto burooyinka, hoos u dhigi karto korriinka ama faafidda burooyinka, oo ay yareyso calaamadaha kansarka qanjirka 'prostate'.

Goobaha codsiga

Warshadaha dawooyinka

Xoogga Hande

Hande waxa uu leeyahay koox R&D sanado badan.Kooxdu waxay dalbatay tiro ikhtiraac ah oo la hal-abuuray, hanaankuna waa mid aan kala go 'lahayn min shaybaadhka ilaa wax soo saarka baaxadda leh ee ganacsiga.Saldhigga wax-soo-saarka GMP ee iskiis u dhisay ayaa ka gudbay dib-u-eegista sharciga ee US FDA, EU EDQM, China GMP, Japan PMDA, Australia TGA, South Korea, India, China Taiwan, Turkey, Russia, SGS, Dun & Bradstreet iyo xeerar kale.Isla mar ahaantaana, shirkadu waxay ku qalabaysan tahay koox cilmi-baaris iyo horumarin ah, waxayna si isdaba-joog ah u heshay tiro ka mid ah shatiyada.Qolka tijaabada QC, si heer sare ah u fahma tijaabada shayga alaabta.

Warshada Hande

Noqo kuwa ugu wanaagsan ee alaabta ceeriin iyo ganacsiyada hufnaan leh!

Ku soo dhawoow inaad ila soo xidhiidho adigoo iimayl u soo dirayamarketing@handebio.com


  • Hore:
  • Xiga: